The Los Angeles Biomedical Research Institute (LA BioMed) is a 501(c)3 independent, non-profit, biomedical research organization founded in 1952. It has over 120 principal investigators and 400 researchers in total (MDs, MD/PhDs and PhDs)—working on over 1,000 research studies.
One of the foremost independent non-profit institute’s in the U.S., LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA, and works in partnership with the Harbor-UCLA Medical Center. They tap into a myriad of financial sponsors for study funding—from government grants (e.g. NIH) to industry sponsors and academic contracts, not to mention private donors and other non-profit foundations.
LA BioMed recently opened a $63-million, four-story, 78,000 square-foot facility, which is one of the most advanced medical research buildings in the country. It contains both wet and dry labs, freezer farms, an auditorium that can seat over 100 people, and an 18,000 square-foot bioscience incubator operated by BioLabs that can host up to 30 bioscience startups and offers $1 million in shared equipment, private offices and meeting space. The new facility should attract many more promising researchers to LA BioMed, which has a track record of successfully commercializing discoveries, having spun off 13 startups in the last 12 years.
- 100+ internationally recognized research groups
- 600 ongoing research projects
- 150 grants from federal sources (NIH and DoD) support the teams
- 500+ peer-reviewed articles in prestigious medical and scientific journals annually
- 200 patents and 15 new filings annually
- 11 start-up spin offs in past decade
LA BioMed is recognized to take on the challenge of devising treatments for debilitating and fatal rare inherited diseases. It currently participates in 25 active clinical trials.
On May 15 at 4 PM, LA BioMed will hold a Pulmonary Open House. A panel of leading pulmonary experts is combined with free health screenings and lung function tests. The event will occur at the Rehabilitation Clinical Trials Center at LA Biomed. Follow the link for more event details. During the event, LA BioMed investigators will address Chronic obstructive pulmonary disease (COPD), the fourth-biggest killer in the U.S., with an estimated 15 million undiagnosed cases. The Rehabilitation Clinical Trials Center at LA BioMed has been running a mobile screening program for the last 15 months. They have tested close to 1,000 individuals, 20% of which were identified with having abnormal lung function. Members from the community can learn more about health options—not to mention the no-cost lung function.